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he GTPase Rab27A interacts with myosin-VIIa and
myosin-Va via MyRIP or melanophilin and mediates
melanosome binding to actin. Here we show that
Rab27A and MyRIP are associated with secretory granules
(SGs) in adrenal chromafﬁn cells and PC12 cells. Overexpres-
sion of Rab27A, GTPase-deﬁcient Rab27A-Q78L, or MyRIP
reduced secretory responses of PC12 cells. Amperometric
recordings of single adrenal chromafﬁn cells revealed that
Rab27A-Q78L and MyRIP reduced the sustained component
of release. Moreover, these effects on secretion were partly
T
 
suppressed by the actin-depolymerizing drug latrunculin
but strengthened by jasplakinolide, which stabilizes the
actin cortex. Finally, MyRIP and Rab27A-Q78L restricted
the motion of SGs in the subplasmalemmal region of
PC12 cells, as measured by evanescent-wave ﬂuorescence
microscopy. In contrast, the Rab27A-binding domain of
MyRIP and a MyRIP construct that interacts with myosin-Va
but not with actin increased the mobility of SGs. We propose
that Rab27A and MyRIP link SGs to F-actin and control
their motion toward release sites through the actin cortex.
 
Introduction
 
Hormones and neuropeptides are stored in secretory granules
(SGs) and released by exocytosis in response to cytosolic
calcium elevation. SGs are formed at the TGN as short-lived
vesicular intermediates, termed immature SGs, and transported
along microtubules to the cell periphery. Immature SGs are
then restricted to the cell periphery within the actin cortex,
a dense network of actin filaments, where they mature
completely (Rudolf et al., 2001). Thus, outward microtubule-
dependent transport and F-actin–dependent capture mediate
the cortical localization of SGs. However, if the actin cortex
may favor peripheral localization of SGs, it may also hinder the
access of vesicles to the plasma membrane. Indeed, the actin
network has a mesh smaller than a granule diameter (Nakata
and Hirokawa, 1992), and it would completely prevent
exocytosis to occur if it were not dynamically remodeled or
severed, in particular upon calcium influx. In adrenal
chromaffin cells, exocytosis occurs preferentially at sites
where the actin cortex has gaps, suggesting that cortical
F-actin acts as a barrier that hampers fusion (Trifaro et al.,
2000). Finally, actin filaments or actin bundles can also
provide tracks on which SGs move in an energy-dependent
manner (Lang et al., 2000; Oheim and Stuhmer, 2000).
Whether F-actin promotes or restricts the mobility of SGs
and their access to the plasma membrane will finally depend
on the dynamics of microfilaments and on the physical
interaction of SGs with F-actin.
A similar actin-dependent capture of the pigment-producing
organelles, termed melanosomes, has been described in skin
melanocytes (Wu et al., 1998), and a detailed molecular
mechanism has been recently provided. The GTP-binding
protein Rab27A, which is associated with the membrane of
melanosomes, recruits melanophilin, the product of 
 
MLPH
 
,
which in turn recruits myosin-VA (Fukuda et al., 2002b;
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Hume et al., 2002; Strom et al., 2002; Wu et al., 2002). In
humans, mutations in 
 
RAB27A
 
 cause Griscelli syndrome, an
autosomal recessive disorder characterized by partial albinism
and uncontrolled T lymphocyte and macrophage activation
(hemophagocytic syndrome) (Ménasché et al., 2000). In me-
lanocytes isolated from these patients or from 
 
ashen
 
 mice bear-
ing loss-of-function mutations in Rab27A, melanosomes are
concentrated in the perinuclear region and cannot accumulate
at the distal ends of the dendritic extensions (Wilson et al.,
2000; Bahadoran et al., 2001; Hume et al., 2001; Wu et al.,
2001). Consequently, melanin cannot be transferred to kera-
tinocytes. Similar impairment of melanosome transport is ob-
served in 
 
leaden
 
 and 
 
dilute
 
 mice bearing mutations in 
 
MLPH
 
(Matesic et al., 2001) and in 
 
MYO5a
 
 (Strobel et al., 1990;
Provance et al., 1996), respectively. These observations indi-
cate that Rab27A, melanophilin, and myosin-VA mediate the
physical link between melanosomes and F-actin.
In retinal pigment epithelial cells, another melanosome-as-
sociated complex made of Rab27A, MyRIP, and myosin-VIIA
was described recently (El-Amraoui et al., 2002). MyRIP was
found to have a broad tissular distribution (Fukuda and
Kuroda, 2002), suggesting that its function may not be re-
stricted to melanosome trafficking. In particular, MyRIP is ex-
pressed in the retinal synaptic region and, upon expression in
pheochromocytoma PC12 cells, was targeted to the tip of neu-
rites that were enriched in SGs. These observations suggested
that Rab27A and MyRIP could have a role in secretory vesicle
trafficking. Consistently, the activity of Griscelli and 
 
ashen
 
 cy-
totoxic T lymphocytes (CTLs) is reduced due to a defect in
lytic granule secretion (Ménasché et al., 2000; Haddad et al.,
2001; Stinchcombe et al., 2001). Moreover, Rab27A is associ-
ated with insulin-containing granules (Yi et al., 2002).
Here we report that Rab27A and MyRIP are associated
with large dense core granules in adrenal chromaffin cells
and pheochromocytoma PC12 cells and control the secre-
tory activity in a manner that depends on the state of the ac-
tin cortex. Moreover, they reduce the mobility of SGs be-
neath the plasma membrane. The results are consistent with
Rab27A and MyRIP bridging vesicles to F-actin and regu-
lating the movement of vesicles within the actin cortex.
 
Results
 
Association of Rab27A and MyRIP with SGs
 
Upon overexpression in PC12 cells, MyRIP was previously
found to be targeted to the tip of neurites where SGs accu-
mulate (El Amraoui et al., 2002). These observations sug-
gested that Rab27A might be responsible for the recruitment
of MyRIP not only on melanosomes but also on SGs. There-
fore, the expression and subcellular localization of Rab27A
and MyRIP were investigated. The monoclonal anti-Rab27A
antibody used in this study did not react with purified re-
combinant Rab3A, B, C, and D, or with Rab4, Rab11, or
GFP–Rab27B transiently expressed in COS-7 cells (unpub-
lished data). Using this antibody, we detected Rab27A in bo-
vine adrenal chromaffin cells and in PC12 cells.
Figure 1. Localization of Rab27A on 
SGs by confocal immunofluorescence. 
Chromaffin cells (A–C) were double 
imaged for endogenous Rab27A (A) and 
chromogranin A/B (B). Discrete punctate 
structures were observed in A and B; 
most of them precisely coincided. See 
the overlaid image (C) and the detail 
shown at higher magnification (inset). 
Anti-Rab27A (D) and anti–chromogranin 
A/B (E) also stained discrete structures 
that coincided (F, overlay) in PC12 cells. 
GFP–Rab27A (G) transiently expressed in 
NGF-treated PC12 cells also colocalized 
with chromogranin B–positive structures 
(H) (I, overlaid image). Note the enrich-
ment of Rab27A and chromogranin B at 
the tip of neurites. In contrast, Rab27A 
(J) did not colocalize with LYAAT, a 
lysosomal marker (K and L). Bars, 5  m.T
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The subcellular localization of Rab27A was investigated by
cell fractionation of chromaffin cells. The protein was hardly
detectable in the cytosol. A crude membrane fraction was sep-
arated on a sucrose gradient. Rab27A, the vesicular mono-
amine transporter VMAT2 and the v-SNARE protein VAMP2
were enriched in the same dense fractions of the gradient, con-
sistent with an association of Rab27A with SGs (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200302157/
DC1). In contrast, the distribution of Rab27A was not similar
to that of lysosomal 
 
 
 
-glucuronidase. MyRIP was detected in
chromaffin and PC12 cell extracts as a single band (
 
 
 
96 kD)
but was not detected in gradient fractions, presumably because
its membrane association is rather labile. Next, the localization
of Rab27A and MyRIP was studied by confocal fluorescence
microscopy. Chromaffin cells labeled with anti-Rab27A anti-
bodies displayed a punctated labeling distributed throughout
the cytoplasm. Moreover, most of the Rab27A-positive struc-
tures were also decorated by an antiserum raised against chro-
mogranin A/B, a component of SG matrix (Fig. 1, A–C), and
by an anti–dopamine 
 
 
 
-hydroxylase, a marker of SG mem-
brane (not depicted). The distribution of Rab27A was also an-
alyzed in NGF-differentiated PC12 cells. As illustrated in Fig.
1 (D–F), the overall distribution of Rab27A was very similar
to that of SGs (stained by an anti–chromogranin A/B antise-
rum), with a marked enrichment at the tip of neurites. Also,
GFP-tagged Rab27A was expressed in PC12 cells, and its lo-
calization was very similar to that of chromogranin B, stained
with a monoclonal antibody (Fig. 1, G–I). In contrast,
LYAAT, an amino acid lysosomal transporter (Sagné et al.,
2001), displayed a very different intracellular distribution (Fig.
1, J–L). Together these results indicate that Rab27A is associ-
ated with SGs.
Next, we investigated the localization of the Rab27A effec-
tor MyRIP by confocal fluorescence microscopy. In NGF-
differentiated PC12 cells, endogenous MyRIP displayed a
punctate distribution very similar to that of Rab27A (Fig. 2,
A–C). In addition, overexpressed MyRIP was targeted to
SGs, as indicated by colocalization of MyRIP with chromog-
ranin B (Fig. 2, D–F) and neuropeptide Y (NPY)–GFP (Fig.
2, G–I). In contrast, no significant overlap was observed be-
tween MyRIP and synaptophysin, a marker of early endo-
somes and synaptic-like microvesicles (not depicted). In
chromaffin cells, endogenous MyRIP also displayed a punc-
tated distribution evenly distributed throughout the cyto-
plasm. When the cells were double imaged for MyRIP and
Rab27A, many structures contained both markers (Fig. 2, J–L).
This is even more evident in Fig. 2 (M–O), which shows
an apical section of a chromaffin cell. Fewer structures could
be seen, and almost all of them contain both MyRIP and
Rab27A. The complete overlap of the two markers in this
Figure 2. Confocal immunofluores-
cence localization of MyRIP on SGs. 
PC12 cells (A–I) were double imaged for 
endogenous Rab27A (A) and MyRIP (B) 
showing discrete punctate structures; 
most of these structures coincided (C, 
overlaid image), especially in the neurites. 
PC12 cells were transfected with 
pCMV-MyRIP and double imaged for 
MyRIP (D and H) and chromogranin B 
(E) or NPY–GFP (G); overlaid images 
indicate that MyRIP colocalized partly 
with chromogranin B (F) and NPY–GFP 
(I). Chromaffin cells (J–O) were imaged 
for endogenous Rab27A (J and M) and 
MyRIP (K and N). Many structures were 
double labeled, as indicated by the 
overlaid image of a cell sectioned close 
to the apex (O). Bars, 5  m.T
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section might suggest that the colocalization of MyRIP and
Rab27A is better at the cell periphery. This is consistent with
results obtained in PC12 cells, where MyRIP was also found
on somatic structures that were not stained with anti-chro-
mogranin or anti-Rab27A antibodies.
Finally, the localization of Rab27A was analyzed at the ul-
trastructural level on ultrathin cryosections of PC12 and chro-
maffin cells. Endogenous MyRIP could not be detected by
immunoelectron microscopy with our antibodies. In PC12
cells, the majority of Rab27A-bound gold particles was associ-
ated with SGs, identified according to their electron-dense
matrix and their size (Fig. 3, A and B). Rab27A labeling was
also found in tubulo-vesicular structures close to the Golgi ap-
paratus, as illustrated in Fig. 3 C. These observations suggest
that Rab27A may have a role at different sites in the secretory
pathway. Quantitative analysis of several sections of PC12
cells revealed that 
 
 
 
92% of Rab27A-associated gold particles
were found on SGs and 8% on vesicles or tubulo-vesicular
profiles located in the vicinity of the Golgi apparatus; 15% of
SGs were depicted with greater than four gold particles. Dou-
ble labeling of sections of chromaffin cells with anti-Rab27A
(15-nm gold particles) and anti-chromogranin (10-nm gold
particles) antibodies revealed a specific association of Rab27A
with SGs (Fig. 3 D). In addition, some immature granules
were labeled (Fig. 3 D, asterisk). Some Rab27A-associated
gold particles seemed to be located within SGs. This was ob-
served also with another anti-Rab27A monoclonal antibody
and in melanosomes (not depicted), suggesting that this ob-
servation is physiologically relevant. Previous reports showed
within SGs the presence of vesicles, reminiscent of exosomes
(Denzer et al., 2000), that are released in the external milieu
during exocytosis (Ornberg et al., 1986).
 
Interaction of MyRIP with myosin-Va and actin
 
MyRIP was initially identified as a ligand of myosin-VIIa.
However, myosin-VIIa was not detected in chromaffin and
PC12 cells (unpublished data). In contrast, myosin-Va is ex-
pressed in chromaffin and PC12 cells, and its association with
SGs was recently demonstrated (Rosé et al., 2003; Rudolf et
al., 2003). Moreover, Fukuda and Kuroda (2002) found
an interaction between full-length MyRIP and myosin-Va.
We confirmed this observation using purified GST-tagged
Figure 3. Ultrastructural localization of Rab27A in PC12 and chromaffin cells. Ultrathin cryosections of PC12 (A–C) and chromaffin cells (D) 
were single or double immunogold labeled for Rab27A (10-nm gold particles, A–C) or Rab27A (15-nm gold particles, D) and chromogranin 
A/B (10-nm gold particles, D). (A and B) Specific labeling of dense core granules of PC12 cells with anti-Rab27A antibodies. A restricted number 
of dense granules show high density of labeling for Rab27A (arrows), whereas others are negative. (C) Rab27A-positive tubulo-vesicular 
structures (arrows) are often observed in the Golgi region. (D) In chromaffin cells, Rab27A localizes to chromogranin-positive SGs (arrows) 
and to immature granules (star). N, nucleus; PM, plasma membrane; GA, Golgi apparatus. Bars, 200 nm.T
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MyRIP constructs. GST–MyRIP-
 
 
 
Cter (1–665) and 
 
 
 
RBD-
 
 
 
Cter (138–665) interacted with the tail of myosin-VIIa and
with myosin-Va (Fig. 4 A). However, the myosin-VIIa– and
myosin-Va–binding domains of MyRIP do not overlap com-
pletely, as MyRIP (1–577) bound to myosin-VIIa (El Am-
raoui et al., 2002) but poorly to myosin-Va (not depicted).
Fukuda and Kuroda (2002) also found an interaction between
MyRIP and actin by coimmunoprecipitation. Deletion of res-
idues 666–859 had little effect on myosin-Va binding (Fig. 4
A) but completely abolished the interaction with actin (Fig. 4
B). The importance of this COOH-terminal region for actin
binding was also demonstrated by immunocytochemistry
(Fig. 4 C). A deletion mutant of MyRIP lacking the Rab27a-
binding domain (MyRIP-
 
 
 
RBD) colocalized with actin,
whereas MyRIP-
 
 
 
RBD-
 
 
 
Cter (138–665), lacking also the
COOH-terminal region required for in vitro actin binding,
gave a diffuse cytosolic staining. This region has significant se-
quence similarity with melanophilin, which was shown to
bind actin directly (Fukuda and Kuroda, 2002).
 
A role for Rab27A and MyRIP in SG exocytosis
 
Overexpressed Rab27A and MyRIP inhibited secretory
responses of PC12 cells. 
 
Then, we investigated whether
Rab27a and MyRIP may control the secretory activity of
PC12 cells. The effect of various constructs was analyzed at
the cell population level by means of two secretion assays
based on cotransfection of vectors encoding either a serotonin
transporter (SERT) or human growth hormone (hGH). Due
to the very high increase in tritiated 5-hydroxytryptamine
([
 
3
 
H]5-HT) uptake induced by SERT, the subpopulation of
transfected cells can be specifically labeled and its secretory ac-
tivity determined by measuring release of [
 
3
 
H]5-HT (Schonn
et al., 2003). hGH is properly targeted to SGs and released in
response to Ca
 
2
 
 
 
 elevation (Wick et al., 1993).
Rab GTPases switch between active GTP-bound and inac-
tive GDP-bound conformations. To investigate the function
of Rab27A in regulated secretion, wild-type Rab27A or mu-
tants defective in GTP binding (T23N) or in GTPase activity
(Q78L) were transiently expressed in PC12 cells. Rab27A-
T23N was supposed to interfere with the function of endoge-
nous protein by competing for a guanine nucleotide exchange
factor that catalyzes the exchange of GTP for GDP. Rab27A-
Q78L was used to increase levels of active GTP-bound
Rab27A. Overexpressed Rab27A and Rab27A-Q78L dis-
played a punctated distribution very similar to that of endoge-
nous Rab27A (Fig. 1, G–I; Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200302157/DC1). In con-
trast, Rab27A-T23N gave a diffuse staining of the cytosol (Fig.
Figure 4. Interaction of MyRIP with myosin-Va 
and actin. (A) Binding of myosin-VIIa tail (left) or 
myosin-Va (middle) to purified GST or GST–MyRIP 
constructs immobilized on glutathione–Sepharose 
beads. Transfected COS-7 cells and nontransfected 
PC12 cells were used as a source of myosin-VIIa 
and myosin-Va, respectively. Cellular levels of 
myosin-VIIa and myosin-Va are shown in the first 
lane of each panel (input, 10% of the volume used 
in the experiment). The position of molecular 
weight markers is shown on the left side ( 10
 3). 
The same blots were stripped and reprobed with 
an anti-GST monoclonal antibody to reveal the 
MyRIP constructs bound to the beads (right). 
Note that deletion of the COOH-terminal region 
of MyRIP had little effect on the interaction with 
myosins. Similar results were obtained in another 
experiment. (B) The COOH-terminal region of 
MyRIP is required for actin binding. COS-7 cells 
were transfected with vectors encoding full-length 
MyRIP (1–859) or a deletion mutant (1–665). The 
proteins expressed were immunoprecipitated
with anti-MyRIP antibody–conjugated protein
A–Sepharose (beads   Ig). Coimmunoprecipitated 
actin was revealed with a monoclonal antibody. 
Beads without antibody were used as control (beads). 
The amount of expressed MyRIP proteins used in 
the immunoprecipitation is shown on the left 
(input, 1/8 of the volume used). Similar results were 
obtained in another experiment. (C) Importance of 
the COOH-terminal region of MyRIP for its 
colocalization with F-actin. PC12 cells were 
transfected with MyRIP- RBD (138–859) (top) or 
MyRIP- RBD- Cter (138–665) (bottom). 3 d later, 
cells were stained with anti–myc tag antibodies 
(left) or rhodamine-phalloidin (middle) and imaged 
by confocal immunofluorescence. The overlaid 
images (right) show that MyRIP- RBD, but not 
MyRIP- RBD- Cter, colocalizes with F-actin.T
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S2). Rab27A-T23N did not induce any significant change
of secretory activity. In contrast, GTPase-deficient Rab27A-
Q78L and, to a less extent, wild-type Rab27A have a pro-
nounced inhibitory effect on secretion (Fig. 5 A). Similar ef-
fects of Rab27A proteins were observed in cells permeabilized
with 
 
 
 
-toxin or streptolysin-O (Rab27A WT: 
 
 
 
24 
 
 
 
 6.5%,
mean 
 
 
 
 SEM, 
 
n
 
 
 
  
 
5 experiments; Rab27A-Q78L: 
 
 
 
57 
 
 
 
4.6%, mean 
 
 
 
 SEM, 
 
n
 
 
 
  
 
3 experiments). As these pore-form-
ing toxins bypass voltage-dependent calcium channels, the in-
hibitory effect of Rab27A was not due to reduced Ca
 
2
 
 
 
 influx.
Rab27A-Q78L inhibited secretory responses over a wide range
of free calcium concentrations without apparent shift in the
calcium sensitivity of the secretory apparatus (unpublished
data). The effect of Rab27A-Q78L was compared with that of
other GTPase-deficient Rab proteins. Rab3A-Q81L inhibited
secretion as previously reported (Johannes et al., 1994; Schonn
et al., 2003), but GFP-tagged Rab8, Rab11, and Rab13 did
not interfere with the secretory activity of PC12 cells (Fig. 5
B), although they were properly expressed (Fig. S3, available
at http://www.jcb.org/cgi/content/full/jcb.200302157/DC1).
Thus, the effect of Rab27A on exocytosis is specific.
Next, we investigated the effect of MyRIP on secretory re-
sponses. Overexpression of full-length MyRIP or of MyRIP-
 
 
 
Cter (1–665) induced moderate but reproducible reduc-
tion of the secretory activity of PC12 cells (Fig. 6). In
contrast, overexpression of MyRIP-
 
 
 
RBD (138–859) slightly
increased secretory responses, while MyRIP-RBD (1–134)
had no significant effect (Fig. 6).
 
Kinetics of secretory responses. 
 
To investigate the site of
action of Rab27A-Q78L, the time course of its effect was in-
vestigated. As illustrated in Fig. 5 C, Rab27A-Q78L had simi-
lar inhibitory effects at various time points (2, 5, and 10 min of
stimulation). Similar results were obtained for MyRIP (not de-
picted). The kinetics of secretory responses was determined
Figure 5. Rab27A controls the magnitude of secretory responses. 
(A) SERT-transfected (black bars) or hGH-transfected PC12 cells 
(gray bars) were cotransfected with vectors encoding untagged 
Rab27A wild type, Rab27A-T23N, or Rab27A-Q78L, as indicated. 
Cells were incubated for 10 min in normal or high K
  saline. Release 
in normal saline medium (2–5% of cellular [
3H]5-HT) was subtracted. 
Results are shown as percentage of the responses of mock-transfected 
cells. Numbers in brackets refer to the number of independent 
experiments. The stimulus-dependent release of control cells ranged 
from 15 to 30% of cellular [
3H]5-HT (mean   20%). (B) Effect of 
GTPase-deficient Rab3A, Rab8, Rab11, and Rab13 on secretory 
responses measured as in A. Rab8, Rab11, Rab13, and Rab27A were 
fused to GFP. Transfection of GFP was used as a control. Results are 
shown as percentage of the depolarization-dependent [
3H]5-HT 
release from control cells (mean   SEM, n   3 independent experi-
ments). Whereas Rab3A-Q81L and GFP–Rab27A-Q78L inhibit PC12 
cell stimulated exocytosis, no effect was observed upon overexpression 
of GFP-tagged GTPase-deficient Rab8, Rab11, or Rab13. (C) [
3H]5-HT 
release as a function of time from control cells ( ) or from cells 
expressing Rab27A-T23N ( ) or Rab27A-Q78L ( ). Cells were 
incubated in normal (dotted line) or high K
  saline (plain line). Results 
are expressed in percentage (mean   SEM, n   3) of total [
3H]5-HT 
present in the cells before stimulation. Similar results were obtained 
in two other independent experiments.
Figure 6. MyRIP controls the magnitude of secretory responses. 
SERT-transfected (black bars) or hGH-transfected PC12 cells 
(gray bars) were cotransfected with vectors encoding wild-type 
MyRIP (MyRIP 1–859), the Rab27A binding domain of MyRIP 
(MyRIP 1–134), a construct lacking the RBD (138–859), or MyRIP-
 Cter (1–665). Cells were incubated for 10 min in normal or high 
K
  saline. Release in normal saline medium was subtracted. Results 
are shown as percentage of the response of mock-transfected cells 
(mean   SEM). The number of experiments performed is shown 
above the bars.T
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more accurately by means of carbon fiber amperometry on sin-
gle chromaffin cells. Exocytosis is resolved by this technique as
a series of current spikes, each spike being produced by the oxi-
dation of the content of a single vesicle (Wightman et al.,
1991). Chromaffin cells were cotransfected with Rab27A-
Q78L or MyRIP and GFP (the latter being used to identify
transfected cells). Cells expressing GFP only were used as con-
trols. Overexpression of Rab27A-Q78L (Fig. 7) or MyRIP
(Fig. 8) induced a significant reduction in spike frequency con-
sistent with a reduction of the sustained phase of the release
process. Rab27A and MyRIP might be implicated in the mo-
tion of vesicles toward the plasma membrane, the docking step,
or the priming reaction, which makes vesicles ready to fuse.
 
Rab27A and MyRIP did not affect spontaneous release.
 
We did not detect any increase in the spontaneous release
of [
 
3
 
H]5-HT in Rab27A- or MyRIP-transfected cells com-
pared with control cells during 10-min (Fig. 5 C) or 1-h
(not depicted) incubations. However, as serotonin is not
stably entrapped within SGs (Schonn et al., 2003), sponta-
neous release of [
 
3
 
H]5-HT during long periods of time
could not be used as a nonambiguous index of constitutive
exocytosis. Released hGH was thus measured in the cell
culture media 3 d after transfection. Compared with con-
trol cells, levels of hGH released from Rab27A WT– or
Q78L-expressing cells were not significantly modified (not
depicted). Furthermore, amperometric recordings did not
detect any increase in spike frequency in the absence of
stimulus (Figs. 7 and 8). These results suggest that the in-
hibitory effect of Rab27A and Rab27A-Q78L on secretory
responses did not result from an increased release activity
in resting conditions.
 
Secretory effects of Rab27A and MyRIP depend on the 
state of actin cortex
 
Biochemical data are consistent with a role for Rab27A and
MyRIP in linking vesicles to F-actin. Entrapment of SGs
within the actin cortex might thus be responsible for their
inhibitory effect on secretory responses. To test this hypoth-
esis, the effect of Rab27A and MyRIP on secretory responses
was measured in cells treated with drugs that interfere with
Figure 7. Rab27A-Q78L reduces the frequency of amperometric 
spikes in chromaffin cells. Secretory responses of single adrenal 
chromaffin cells were monitored by carbon fiber amperometry. 
(A) Amperometric trace recorded from a GFP-transfected (CTL) 
chromaffin cell stimulated by local application of 10  M nicotine 
(indicated by the bar below the trace). (B) Secretory response of a 
Rab27A-Q78L–expressing cell. (C) The cumulative number of 
spikes is plotted against time. Shown are the mean values ( SEM) 
from 17 cells (CTL) and 6 cells (Rab27A-Q78L). The bar above the 
traces indicates the presence of nicotine. The significance of 
difference was calculated with Mann-Whitney test.
Figure 8. Overexpression of MyRIP reduces the frequency of 
amperometric spikes in chromaffin cells. Secretory responses of single 
adrenal chromaffin cells were monitored by carbon fiber amper-
ometry. (A) Amperometric trace recorded from a GFP-transfected 
(CTL) chromaffin cell stimulated by local application of high K
  
(55 mM) saline (indicated by bars below the trace). (B) Secretory 
responses of a wild-type MyRIP (MyRIP-FL)–transfected cell. (C) The 
cumulative number of spikes is plotted against time. Shown are the 
mean values ( SEM) from 18 cells (CTL) and 16 cells (MyRIP-FL). 
The bars indicate the application of high K
 . The significance of 
difference was calculated with Mann-Whitney test.T
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actin polymerization. Latrunculins favor actin depolymeriza-
tion (Spector et al., 1983; Lang et al., 2000), whereas jas-
plakinolide promotes actin polymerization (Fig. 9 A). Under
the conditions used, latrunculin B increased the secretory ac-
tivity, while jasplakinolide had no significant effect on secre-
tion. In latrunculin B–treated cells, the inhibitory effect of
Rab27A-Q78L was significantly reduced compared with the
one observed in the absence of drug (Fig. 9 B). Latrunculin
B also reduced the effect of MyRIP. On the other hand, the
inhibition of secretion induced by MyRIP overexpression
was much stronger after jasplakinolide treatment than in
standard conditions (Fig. 9 B). This effect is probably medi-
ated by direct interaction of MyRIP with F-actin because it
was not observed with MyRIP- Cter. The effect of gran-
uphilin, another putative effector of Rab27A, was not in-
creased by jasplakinolide (Fig. 9 B). In contrast to drugs that
act on the actin cortex, microtubule depolymerization by
nocodazole did not modify the effect of Rab27A and MyRIP
(not depicted). The inhibitory effect of Rab27A and MyRIP,
which does not by itself modify the actin cortex (not de-
picted), is thus partly dependent on the integrity and dy-
namics of the cytoskeleton.
Rab27A and MyRIP restrict granule motion
Evanescent wave fluorescence microscopy (EW-FM) allows
observation of fluorescent markers in a thin optical section
near a glass–water interface. PC12 cells cultured on the glass
interface were transfected with a NPY–GFP construct to la-
bel SGs and imaged with this technique. Under these condi-
tions, the fluorescent SGs close to the plasma membrane
were easily observed (Fig. 10 A), and their individual behav-
ior was recorded with a CCD camera (Fig. 10 B). The inten-
sity of the evanescent wave decreased exponentially with the
distance from the interface with a decay constant in the cell
adjusted to 200 nm. According to previous studies in PC12
cells (Lang et al., 2000), most of SGs imaged by this tech-
nique are located in the actin cortex.
The mobility of SGs in unstimulated cells was analyzed in
1-min sequences of 120 frames (Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200302157/DC1). Most
of the vesicles had limited movements (Fig. 10 B, arrow-
head), but some moved on longer distances (Fig. 10 B, ar-
row). The x,y trajectories were monitored using a single par-
ticle tracking software (Fig. 10, C and D), and the mean x,y
diffusion coefficients (Dx,y) were derived from mean square
displacement (MSD) analysis.
Rab27A-Q78L or various MyRIP constructs were tran-
siently expressed in PC12 cells together with NPY–GFP
(see Videos 1–5 for representative examples, available at
http://www.jcb.org/cgi/content/full/jcb.200302157/DC1).
All SGs that could be followed for  15 s were tracked (150–
700 SGs from 15–60 cells per group). Expression of
Figure 9. The effects of Rab27A-Q78L and MyRIP on 
secretion depend on the state of the actin cortex. 
(A) Rhodamine-phalloidin staining of the actin cortex of 
PC12 cells. Compared with control conditions (left), the 
thickness of actin is reduced upon latrunculin B treatment 
(middle) and increased by jasplakinolide (right). (B) The 
secretory activity of PC12 cells transfected with vectors 
encoding GFP (as control), Rab27A-Q78L, wild-type MyRIP 
(MyRIP 1–859), MyRIP- Cter (1–665), or granuphilin was 
measured as in Fig. 5 by means of the [
3H]5-HT release 
assay. Cells were incubated without addition of drug (Std, 
black bars) or in the presence of 1  M jasplakinolide (Jasp, 
open bars) or 5  M latrunculin B (Lat B, gray bars) for 20 min 
before and during stimulation of secretion. The effect of the 
different proteins on secretion was expressed, after subtracting 
the basal release of [
3H]5-HT in normal saline, as percentage 
of the stimulus-dependent secretory response of GFP-trans-
fected cells measured under the same conditions (i.e., in the 
absence of drug, in the presence of jasp, or in the presence 
of lat B). Shown are the results (mean   SEM) of several independent experiments (the number of experiments is shown above the bars). 
Latrunculin B significantly reduced (P   0.001) the inhibitory effects of Rab27A-Q78L and MyRIP on secretion, whereas jasplakinolide increased 
that of MyRIP (P   0.001). The net release of GFP-transfected cells was 19   2% of cellular [
3H]5-HT in the absence of drug, 20   2.2% in 
the presence of jasplakinolide, and 31   3% in the presence of latrunculin B.T
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Rab27A-Q78L or MyRIP clearly shifted the distribution of
Dx,y toward lower values (not depicted) and lowered the
mean diffusion coefficient (Fig. 10 E), indicating reduced
mobility of SGs. In contrast, expression of MyRIP-RBD
and MyRIP- Cter increased the mean diffusion coefficient.
None of these proteins affected the mean number of SGs per
area unit (unpublished data). In latrunculin-treated cells, SG
mobility was enhanced but was insensitive to MyRIP over-
expression (Fig. 10 E, right).
Discussion
The data presented here suggest that Rab27A and MyRIP
provide a link between SGs and F-actin, and control short-
range movements of SGs beneath the plasma membrane and
their access to exocytotic sites. Our results indicate that
MyRIP and Rab27A are associated with SGs. This conclu-
sion is supported by different approaches. First, Rab27A
cofractionates with VMAT2 and VAMP2 in sucrose gra-
dients of chromaffin cell extracts. Second, Rab27A and
MyRIP colocalize with chromogranins in confocal sections
of PC12 and chromaffin cells. Third, Rab27A colocalizes
with SGs by immunoelectron microscopy. Interestingly, in
several cases, Rab27A-associated gold particles were found in
small clusters, suggesting that Rab27A may define micro-
domains on SGs, as was proposed for Rab5 on endosomes
(Sönnichsen et al., 2000). The association of Rab27A with
SGs is consistent with recent findings obtained by Fukuda et
al. (2002a). Rab27A and Rab27B have also been found on
insulin-containing granules (Yi et al., 2002; Zhao et al.,
2002) or platelet-dense or   granules (Barral et al., 2002).
Moreover, Rab27A is involved in the regulation of CTL
exocytosis at the immunological synapse (Ménasché et al.,
2000; Haddad et al., 2001; Stinchcombe et al., 2001).
Therefore, Rab27A and maybe Rab27B are associated with a
broad range of secretory vesicles, and not only with typical
lysosome-related organelles.
In agreement with the localization of Rab27A on SGs, the
Rab27A-binding protein MyRIP colocalized with Rab27A
and SG markers. The granular localization of MyRIP de-
pends on its NH2-terminal Rab27A-binding domain be-
cause truncated constructs lacking this domain are mislocal-
ized (El-Amraoui et al., 2002; Fig. 4 C).
Studies on Griscelli syndrome or ashen CTLs lacking
Rab27A revealed a defect in lytic granule exocytosis, suggest-
ing that Rab27A is an essential component of the secretory
machinery. During completion of this study, Fukuda et al.
(2002a) reported that overexpression of wild-type Rab27A
Figure 10. Rab27A and MyRIP control the motion of 
SGs beneath the plasma membrane. (A) Intact PC12 cell 
expressing NPY–GFP. The cell was illuminated by evanescent 
field with a penetration depth of 200 nm (in the cell) to 
visualize the NPY–GFP-containing SGs. The image is taken 
from a 1-min sequence acquired at 2 Hz (Video 5, available 
at http://www.jcb.org/cgi/content/full/jcb.200302157/DC1). 
(B) Series of images of the area delineated in A taken at 5-s 
intervals. (C) The granule marked with an arrow in B was 
tracked as described in the Materials and methods. Shown 
is the x,y trajectory. (D) Track of the granule marked with 
an arrowhead in B. Bars, 1 µm. (E) PC12 cells were 
cotransfected with NPY–GFP and Rab27A-Q78L or different 
MyRIP constructs. 3 d later, cells were imaged by EW-FM 
with a penetration depth of 200 nm (in the cell). SGs were 
tracked and the 2D diffusion coefficient (Dx,y) of each SG 
was calculated as described in the Materials and methods. 
Shown is the mean ( SEM) of Dx,y measured in mock-
transfected (Control) and Rab27A-Q78L, MyRIP (1-859), 
MyRIP-RBD (1-134), and MyRIP- Cter (1-665) transfected cells. Latrunculin B (Lat B, right) increased the mean Dx,y of control cells. Moreover, 
under these conditions, the mobility of SGs from MyRIP-expressing cells was not different from that of mock-transfected cells. The number of 
tracked SGs is indicated above the bars. The significance of the differences was measured with Mann-Whitney U test.T
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increased the secretory activity of PC12 cells. Similar effects
of Rab27A on insulin secretion were also reported recently
(Yi et al., 2002). In chromaffin and PC12 cells, we found by
several approaches that Rab27A and, more especially, GTP-
ase-deficient Rab27A (that is properly targeted to SGs; Fig.
S2) reduced the magnitude of the secretory response (Figs.
5–9). Rab27A-Q78L reduced not only the amount of re-
leased secretory products but also the frequency of release
events, as measured by carbon fiber amperometry. This ap-
parent discrepancy might result from differences in assays
used to measure secretion, from the relative importance of
various Rab27A effectors in different cells, or from a rate-
limiting effect of GTP hydrolysis by Rab27A. An increased
probability of spontaneous fusion does not seem to account
for the observed inhibition of stimulus-dependent release by
Rab27A and Rab27A-Q78L, as was proposed recently by
Schlüter et al. (2002) for Rab3A, another GTPase associated
with SGs. Indeed, we did not detect any significant increase
in release activity in the resting state.
Our observations suggest that MyRIP mediates, at least
partly, the effect of Rab27A on secretion and provides a phys-
ical link between SGs and actin. Indeed, both proteins re-
duced the “sustained” component of release that involves re-
cruitment of vesicles from the “reserve” pool. Moreover, both
Rab27A- and MyRIP-induced effects on secretion were mod-
ulated by drugs that affect the actin cortex. Latrunculin B,
which reduces the thickness of the actin cortex, also reduced
the inhibitory effects of Rab27A-Q78L and MyRIP, while the
actin-stabilizing drug jasplakinolide strongly strengthened the
effect of MyRIP (Fig. 9). Finally, both MyRIP and Rab27A-
Q78L restrict the motion of SGs in the actin-rich region of
the cell imaged by EW-FM, whereas MyRIP-RBD and
MyRIP- Cter, which are supposed to reduce the association
of endogenous MyRIP with Rab27A, enhanced the mobility
of SGs (Fig. 10 E). Latrunculin was found to increase SG mo-
bility in mock-transfected cells, in agreement with F-actin act-
ing as a barrier, and to prevent the effect of MyRIP on SG
motion, in agreement with MyRIP tethering SGs to F-actin.
Previous studies revealed that SGs are captured at the cell
periphery by a process involving both microfilaments and mi-
crotubules (Rudolf et al., 2001). MyRIP and Rab27A may
play a role in SG capture similar to that of Rab27A/melano-
philin/myosin-Va in the actin-dependent retention of mela-
nosomes. However, if actin filaments may favor the retention
of SGs at the cell periphery, they also hamper the diffusion of
SGs toward the plasma membrane, as indicated by the in-
crease in SG mobility and release induced by latrunculin.
MyRIP may link SGs to actin via myosin-Va, which was re-
cently shown to favor the dispersion of immature SGs within
the actin cortex (Rudolf et al., 2003) and to be involved in se-
cretion (Rosé et al. 2003). Recruitment of a molecular motor
might indeed promote the motion of SGs within the actin
cortex. MyRIP may also link SGs to actin filaments via a my-
osin-independent mechanism involving the COOH-termi-
nal region of MyRIP (Fig. 4; Fig. S4, available at http://
www.jcb.org/cgi/content/full/jcb.200302157/DC1). This re-
gion displays significant sequence similarity with the actin-
binding domain of melanophilin, suggesting that MyRIP may
also bind F-actin directly. Our data indicate that this myosin-
independent binding of MyRIP to actin is responsible for the
restricted mobility of SGs. Indeed, SG motion was reduced by
MyRIP but increased by MyRIP- Cter, which binds to myo-
sin-Va but not to actin (Fig. 4). The motion of SGs within
the actin cortex thus depends on the dynamics of actin re-
modeling and of Rab27/MyRIP/actin interaction.
The inhibition of secretion observed upon expression of
Rab27A or MyRIP is apparently correlated with the re-
stricted motion of SGs within the actin cortex. In the case of
MyRIP, both effects display the same dependence on actin
organization. Clearly, increasing the degree of actin poly-
merization (by jasplakinolide) and the interaction of SGs
with actin (by MyRIP) is detrimental to the secretory pro-
cess, most likely by preventing the access of SGs to release
sites. However, MyRIP- Cter, which increased SG mobil-
ity, also reduced the magnitude of the secretory response. In
this case, the effect on secretion was not strengthened by jas-
plakinolide. This result suggests that MyRIP may interfere
with the secretory process via another mechanism. This hy-
pothesis deserves further study. It will also be interesting to
investigate the putative function of MyRIP in other secret-
ing cells such as CTLs and neurons.
Materials and methods
Materials
The rabbit anti-MyRIP antibody and the anti–myosin-VIIa antibody were
described previously (El Amraoui et al., 2002). Anti-LYAAT and anti-
VMAT2 rabbit antisera were provided by B. Gasnier and C. Sagné (CNRS,
Institut de Biologie Physico-Chimique); the anti–chromogranin B monoclo-
nal antibody was a gift of W. Huttner (Max Planck Institute of Molecular
Cell Biology and Genetics, Dresden, Germany); the anti–myosin-Va was
provided by R. Cheney (University of North Carolina, Chapel Hill, NC).
Anti-Rab27A monoclonal antibody was from Transduction Laboratories;
anti–chromogranin A/B polyclonal antibody was from Abcam; anti-
VAMP2 was from Synaptic Systems; anti-actin was from Sigma-Aldrich;
and the myc tag 9B11 antibody was from Cell Signaling Technology.
Plasmid encoding rat SERT (pcDNA3-SERT) and NPY–GFP were pro-
vided by R. Blakely (Vanderbilt University School of Medicine, Nashville,
TN) and W. Almers (Oregon Health Sciences University, Portland, OR), re-
spectively. pcDNA3-granuphilin was a gift of R. Regazzi (University of Lau-
sanne, Lausanne, Switzerland). pEGFP-C1 was from BD Biosciences Clon-
tech. Other plasmids encoding MyRIP and Rab27A constructs were
described previously (El-Amraoui et al., 2002; Ménasché et al., 2003).
Streptolysin-O and  -toxin were obtained from S. Bhakdi (Johannes Guten-
berg University, Mainz, Germany) (Bhakdi et al., 1993). Latrunculin B and
jasplakinolide were from Calbiochem. Other chemicals were purchased
from Sigma-Aldrich.
Cell culture and transfection
Primary dissociated chromaffin cells from bovine adrenal medulla were
prepared by retrograde collagenase perfusion and cultured as previously
described (Darchen et al., 1990). PC12 cells were cultured and transfected
as described previously (Schonn et al., 2003). Where indicated, NGF (50
 g/ml) was added to the culture medium. COS-7 cells were cultured in
DME supplemented with 10% FBS at 37 C under 5% CO2. Chromaffin and
COS-7 cells were transfected by electroporation using Optimix electropo-
ration kit (Equibio). In brief, freshly prepared cells were suspended in Opti-
mix buffer A and collected by centrifugation (800 g, 10 min). Cells (1.5  
10
6) were resuspended in 55  l Optimix buffer B containing vector DNAs
(5  g). A single electric shock (PC12: 650 V/cm, 24 ms; COS: 625 V/cm,
8   3 ms) was applied using a PS10 electropulsator (Jouan). Electroporated
cells were immediately recovered in warm culture medium and plated
onto polylysine-coated glass coverslips. Experiments were generally per-
formed 3 d after transfection.
Immunoelectron microscopy
PC12 and chromaffin cells were fixed with 2% paraformaldehyde in 0.2 M
phosphate buffer, pH 7.4, for 1 h at room temperature. Cells were embed-
ded in 10% gelatin, infused in 2.3 M sucrose, and frozen in liquid nitrogenT
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as described in detail previously (Raposo et al., 1997). Ultrathin cryosec-
tions were prepared with a Leica FCS ultracryomicrotome (Leica) and
single and double immunogold labeled with a mouse monoclonal anti-
Rab27A antibody and a rabbit polyclonal anti–chromogranin A/B accord-
ing to Slot et al. (1991). A rabbit anti–mouse IgG was used after the first in-
cubation with the monoclonal anti-Rab27A antibody. Protein A–gold
conjugates (PAG 10 and PAG 15) were purchased from the Department of
Cell Biology, Utrecht University, Utrecht, Netherlands. Relative quantita-
tion of the immunogold labeling for Rab27A was performed directly under
the electron microscope by counting 650 gold particles associated with
the different subcellular compartments of PC12 cells. 560 granules were
analyzed for the presence of Rab27A.
Interaction assays
GST and GST-MyRIP constructs were expressed in E. coli BL21 cells and
purified by affinity chromatography onto glutathione–Sepharose (Amer-
sham Biosciences) using standard procedures.
Pull Down.  Myosin-VIIa tail (El Amraoui et al. 2002) was expressed in
COS-7 cells. Transfected COS-7 cells or PC12 cells were scrapped, soni-
cated, and solubilized at 4 C for 30 min in a buffer containing 1% Triton
X-100, 150 mM NaCl, 25 mM Tris-Cl, pH 7.5, 2 mM ATP, and a cocktail
of proteases inhibitors. After centrifugation (12,000 g, 15 min), superna-
tants (0.5–1 mg protein) were incubated for 1 h at 4 C under agitation with
1 nmol of purified GST or GST–MyRIP constructs prebound to 150  l glu-
tathione–Sepharose beads. The beads were washed three times in 150 mM
NaCl, 25 mM Tris-Cl, pH 7.5, and eluted in Laemmli sample buffer. Start-
ing material and eluates were analyzed by SDS-PAGE and immunoblotting
for the presence of myosin-Va or -VIIa.
Coimmunoprecipitation.  COS-7 cells were transfected 2 d before the ex-
periment with vectors encoding myc-tagged MyRIP or MyRIP- Cter
(1–665). Cells were lysed as described above. Extracts were incubated with
protein A–Sepharose beads (100  l wet volume; Amersham Biosciences)
conjugated with or without affinity-purified anti-MyRIP antibody. After
three washes, the eluates were analyzed by SDS-PAGE and immunoblot-
ting for the presence of MyRIP (with an anti–c-myc tag antibody) or actin.
Secretion assays
The [
3H]5-HT release assay has been described previously (Schonn et al.,
2003). In brief, PC12 cells were transfected with the serotonin transporter
SERT, loaded with [
3H]5-HT (5–20 Ci/mmol; Amersham Biosciences).
Basal release was measured in Locke’s solution containing (in mM) NaCl
154, KCl 5.5, glucose 5.6, NaHCO3 3.5, CaCl2 2.5, MgCl2 1.2, Hepes 15,
and 0.2% BSA, pH 7.4, adjusted with NaOH supplemented with 1  M
clomipramine. Secretion was measured at 37 C in high K
  Locke’s solu-
tion (55 mM K
  with Na
  reduced to 104.5 mM) in the presence of 1  M
clomipramine. After 2–10 min, the radioactivity released in the medium
and remaining in the cells was measured. Alternatively, cells were rinsed
twice with Ca
2 -free Locke’s solution and permeabilized for 4 min at 37 C
with 20  M digitonin or 22 U streptolysin-O in (in mM) potassium
glutamate 139, Pipes 20, HEDTA 2, EGTA 2, free Mg
2  1, ATP 2, plus
0.3% BSA and pH adjusted to 7 using KOH. Secretion was then elicited in
the same medium supplemented with 30  M free Ca
2 , for 5 min at 37 C.
Free Ca
2  concentrations were calculated according to Föhr et al. (1993)
using calcv.22 software. Where indicated, cells were treated with 1  M
jasplakinolide or 5  M latrunculin B for 20 min before being stimulated to
secrete (in the continuing presence of the drug). The hGH release assay
and amperometric recordings were performed as described previously
(Schonn et al., 2003).
EW-FM
An upright microscope (Olympus BX50WI) has been adapted to EW-FM
by the prism approach (Axelrod, 1981). To excite fluorescence, light from
an argon laser set at 488 nm (Spectra Physics 177-G02) entered radially a
hemispheric BK7 glass prism and struck its planar face at a supercritical
angle. The angle was adjustable by means of telecentric optics to be de-
scribed elsewhere, and the evanescent field decay length was calculated
assuming a refractive index of 1.37 for the cellular medium (experimen-
tally determined). NPY–GFP-transfected PC12 cells cultured on polylysine-
coated glass coverslips were observed in Locke’s solution. Coverslips were
optically coupled to the planar face of the prism with immersion oil (Carl
Zeiss MicroImaging, Inc.). The laser intensity was attenuated to  1 mW,
and illumination was restricted to image acquisition by a shutter coupled
to the camera. The cells were observed through a water immersion objec-
tive 60X 0.9 NA (Olympus), and the images were captured with a CDD
camera (Photometrics CoolSnap HQ; Roper Scientific). In the present
work, frames were acquired at 2 Hz in stacks of 120 images. Exposure
times were of 100–300 ms, depending upon the signal to noise ratio, and
under these conditions,  5% photobleaching occurred.
Analysis of SG motion
The positions of SGs in an x,y plane parallel to the membrane glass inter-
face were determined using software modules provided by Metamorph
(Universal Imaging). Occasionally, the image stacks were processed by a
long pass filter (Steyer and Almers, 1999) before tracking the vesicles. For
tracking, SGs that did not collide with neighboring granules and that stay
bright for at least 30 images (15 s) were selected. A threshold brightness was
then chosen, resulting in binary stacks where SGs appeared as single con-
tinuous regions of bright pixels. The position of the tracked SGs was deter-
mined as the mass center of these contiguous bright pixels. The trajectories
were derived from the SG positions on each frame. For each SG trajectory,
the MSD in the x,y plane was calculated according to Steyer and Almers
(1999). Plots of MSD as a function of  t were linear for  t   5 s, and a two-
dimension diffusion constant Dx,y was derived from the slope of the curve.
Statistical analyses
Significance of differences was calculated with t test or Mann-Whitney U
test; *, P   0.05; **, P   0.01; ***, P   0.001.
Online supplemental material
The supplemental material (Figs. S1–S4, Videos 1–5, and supplemental
Materials and methods) is available at http://www.jcb.org/cgi/content/full/
jcb.200302157/DC1. Fig. S1 shows the presence of Rab27A in subcellular
fractions enriched in SGs. Fig. S2 shows the distribution of Rab27A con-
structs in PC12 cells. Fig. S3 illustrates the cellular expression of the differ-
ent constructs used in this study. Fig. S4 depicts how Rab27A and MyRIP
may bridge SGs to actin. The videos illustrate the effect of Rab27A and
MyRIP on SG motion. Plasmid constructions and protocols used for immu-
nocytochemistry and subcellular fractionation are described in the supple-
mental Materials and methods.
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